CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

Historical Holders from Q1 2019 to Q3 2025

Symbol
CVAC on Nasdaq
Type / Class
Equity / Common Shares, par value (euro)0.12 per share
Shares outstanding
22.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
19.6M
Holdings value
$105M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
92
Number of buys
38
Number of sells
-38
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 19.6M $105M +$42.9M $5.39 92
2025 Q2 11.5M $62.5M +$21.4M $5.43 88
2025 Q1 7.87M $21.8M -$778K $2.77 81
2024 Q4 7.86M $26.6M -$5.84M $3.41 74
2024 Q3 11.1M $32.8M -$7.04M $2.94 78
2024 Q2 14.2M $48.3M -$9.34M $3.40 85
2024 Q1 15.9M $48.3M -$19.7M $3.03 88
2023 Q4 22.2M $93.4M -$57.8M $4.21 88
2023 Q3 33.7M $230M -$14.9M $6.83 84
2023 Q2 35.7M $373M -$7.72M $10.42 86
2023 Q1 36.7M $256M +$175M $6.97 81
2022 Q4 11.6M $70M +$26.2M $6.03 79
2022 Q3 7.15M $56.4M -$15.4M $7.88 76
2022 Q2 8.41M $114M -$92.5M $13.61 79
2022 Q1 14.4M $283M -$10M $19.61 103
2021 Q4 14.6M $503M +$22.4M $34.31 99
2021 Q3 13.7M $750M -$11.7M $54.62 104
2021 Q2 10.7M $789M -$28.3M $73.48 104
2021 Q1 14.1M $1.28B +$338M $91.46 83
2020 Q4 7.25M $588M -$18.7M $81.07 58
2020 Q3 7.61M $355M +$355M $46.55 42
2020 Q2 108 $8K $74.07 1
2020 Q1 108 $8K $74.07 1
2019 Q4 108 $8K $74.07 1
2019 Q3 108 $8K $74.07 1
2019 Q2 108 $8K $74.07 1
2019 Q1 108 $8K $74.07 1